ヒドロモルフォンによるオピオイドアゴニスト治療への関心に関する性別差:注射器サービスプログラム参加者の横断的な研究
Vitaliy Lasiychuk1, Megan Ghiroli1,2, Teresa López-Castro3
1Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY, 10461, USA.
Harm reduction journal
|August 29, 2025
まとめ
ヒドロモルフォン (iOAT- H) による注射性オピオイドアゴニスト治療への関心は,女性と男性の両方にとって高いものでした. 女性はOUDに関連したリスクが多く,IOAT-Hを好むと報告し,未満たされた治療の必要性を示唆しました.
科学分野:
- 依存症 医学
- 公衆衛生
- 医学におけるジェンダー研究
背景:
- オピオイド使用障害 (Opioid Use Disorder, OUD) は米国で治療率が低い数百万人に影響しています
- ヒドロモルフォン (iOAT- H) を用いた注射オピオイドアゴニスト治療は,新しいOUD治療である.
- OUD を 持つ 女性 は 独特 な 課題 に 直面 し て い ます.また,治療 に 関し て 関心 が 異なっ て いる こと も あり ます.
研究 の 目的:
- iOAT-Hに対する女性の態度を評価する.
- OUDに関連するリスクにおけるジェンダーの格差を特定する.
- OUDの治療におけるジェンダー特有の潜在的なニーズを探求する.
主な方法:
- 横断的な研究の二次分析
- iOAT-Hの関心とOUDのリスクに関する都市注射器サービスプログラムの参加者を調査した.
- 治療の好みを評価し,性的差異を記述的統計を用いて比較した.
主要な成果:
- 女性 (68%) と男性 (64%) が,IOAT-Hに対する高い関心を示した.
- 女性はIOAT-H (56%) を好み,男性はメタドン (42%) を好む.
- 女性では,OUDに関連するリスクが高く,毎日の注射や公共の場で注射する頻度が高く報告されています.
結論:
- iOAT-Hは女性に受け入れられ,多くの方が好む.
- OUDのリスクにおける男女差は 女性の満たされていないニーズを示唆しています
- トラウマや女性のための安全な治療スペースの創出といった 特定のリスクに関するさらなる研究が必要です
関連する概念動画
Opioid Analgesics: Synthetic and Semisynthetic Opioids
421
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
421
Opioid Receptors: Overview
1.8K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.8K
Opioid Analgesics: Morphine and Other Natural Cogeners
361
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
361
Analgesia and Pain Management
788
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
788
Drug-Receptor Interaction: Agonist
2.8K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.8K
Drug Abuse and Addiction: Pharmacological Phenomena
655
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
655


